| Estimated Vaccination Coverage*,† with Selected Vaccines Among Adolescents 13-17 Years of Age§ by Poverty Level¶ and Race/Ethnicity** -- National Immunization Survey-Teen, United States, 2008 |
| Total % (95% CI) | White only, non-Hispanic % (95% CI) | Black only, non-Hispanic % (95% CI) | Hispanic % (95% CI) | American Indian or Alaska Native only, non-Hispanic % (95% CI) | Asian only, non-Hispanic % (95% CI) | ||
|---|---|---|---|---|---|---|---|
| >2 MMR†† | US National | 89.3 (88.4-90.2) | 89.9 (88.8-90.8) | 89.1 (86.5-91.2) | 87.5 (84.4-90.0) | 93.9 (88.3-96.9) | 87.2 (77.3-93.1) |
| At or Above Poverty | 89.6 (88.6-90.6) | 89.7 (88.5-90.8) | 88.6 (84.9-91.5) | 90.4 (87.3-92.8) | 92.7 (85.1-96.5) | 86.6 (74.4-93.5) | |
| Below Poverty | 87.1 (84.1-89.6) | 89.2 (86.0-91.7) | 89.1 (85.0-92.1) | 83.9 (77.5-88.8) | 95.2 (79.7-99.0) | 92.2 (73.7-98.0) | |
| Unknown Poverty | 91.2 (87.4-93.9) | 93.3 (89.5-95.7) | 95.8 (89.3-98.4) | 86.4 (72.3-93.9) | NA | NA | |
| > 3 HepB§§ | US National | 87.9 (86.9-88.8) | 88.1 (87.0-89.1) | 86.0 (83.3-88.3) | 89.8 (87.0-92.0) | 86.6 (77.6-92.4) | 89.9 (80.0-95.2) |
| At or Above Poverty | 88.0 (87.0-89.1) | 87.9 (86.7-89.0) | 85.8 (82.2-88.8) | 92.1 (89.3-94.3) | 88.3 (79.6-93.6) | 89.4 (77.0-95.5) | |
| Below Poverty | 86.7 (83.9-89.1) | 88.4 (85.1-91.0) | 86.9 (82.3-90.4) | 86.2 (80.3-90.6) | 80.4 (55.1-93.2) | 93.2 (79.4-98.0) | |
| Unknown Poverty | 89.8 (85.7-92.9) | 90.9 (84.9-94.7) | 82.9 (67.1-92.1) | 92.4 (85.8-96.1) | NA | NA | |
| > 1 Var¶¶ | US National | 81.9 (80.2-83.6) | 82.8 (81.0-84.5) | 74.0 (68.4-78.9) | 84.5 (79.0-88.8) | 83.5 (68.4-92.2) | 89.1 (82.0-93.6) |
| At or Above Poverty | 82.9 (81.2-84.5) | 82.9 (80.9-84.7) | 74.8 (68.1-80.6) | 88.9 (84.5-92.2) | 92.2 (80.4-97.2) | 88.1 (79.2-93.6) | |
| Below Poverty | 77.0 (71.1-82.1) | 74.4 (66.4-81.1) | 72.7 (61.5-81.7) | 80.0 (68.9-87.8) | NA | NA | |
| Unknown Poverty | 87.5 (82.1-91.5) | 90.5 (83.8-94.6) | 72.4 (52.7-86.0) | 85.1 (69.1-93.6) | NA | NA | |
| > 1 Td or Tdap*** | US National | 72.2 (70.8-73.4) | 71.6 (70.1-73.0) | 71.4 (67.6-74.9) | 74.1 (70.0-77.8) | 81.4 (72.6-87.8) | 76.9 (67.2-84.4) |
| At or Above Poverty | 72.7 (71.3-74.1) | 72.3 (70.8-73.8) | 71.9 (67.0-76.2) | 75.7 (70.9-80.0) | 76.8 (64.8-85.6) | 76.6 (64.8-85.3) | |
| Below Poverty | 70.9 (67.0-74.4) | 64.5 (59.3-69.3) | 68.9 (61.8-75.3) | 74.8 (67.7-80.8) | 87.4 (72.8-94.8) | 68.4 (45.5-84.8) | |
| Unknown Poverty | 68.3 (60.2-75.5) | 67.5 (57.3-76.3) | 82.7 (69.9-90.8) | 57.7 (37.9-75.3) | NA | NA | |
| > 1 Tdap††† | US National | 40.8 (39.3-42.2) | 41.7 (40.1-43.3) | 36.0 (31.9-40.2) | 41.9 (37.5-46.5) | 43.5 (31.7-56.1) | 44.4 (34.4-54.9) |
| At or Above Poverty | 41.2 (39.7-42.8) | 42.5 (40.8-44.1) | 33.4 (29.2-37.9) | 44.0 (38.5-49.7) | 40.2 (27.1-55.0) | 42.3 (31.0-54.6) | |
| Below Poverty | 38.6 (34.2-43.2) | 32.8 (28.0-38.0) | 39.0 (30.8-47.9) | 40.4 (32.6-48.7) | 51.1 (27.3-74.4) | NA | |
| Unknown Poverty | 41.1 (34.6-48.0) | 39.9 (32.0-48.3) | 50.1 (30.8-69.4) | 34.9 (22.2-50.3) | NA | NA | |
| > 1 MCV4§§§ | US National | 41.8 (40.3-43.2) | 39.7 (38.2-41.2) | 43.1 (39.0-47.3) | 46.8 (42.2-51.4) | 47.3 (35.4-59.5) | 50.5 (40.3-60.8) |
| At or Above Poverty | 42.0 (40.5-43.5) | 40.3 (38.7-41.9) | 44.7 (39.7-49.8) | 48.9 (43.3-54.5) | 41.3 (28.1-55.8) | 49.2 (37.4-61.1) | |
| Below Poverty | 40.8 (36.6-45.2) | 32.8 (28.0-37.9) | 38.8 (31.9-46.2) | 45.0 (37.1-53.2) | 62.6 (39.5-81.1) | NA | |
| Unknown Poverty | 40.9 (34.5-47.6) | 37.3 (30.3-44.9) | 50.5 (31.2-69.6) | 41.0 (25.7-58.3) | NA | NA | |
| > 1 HPV4¶¶¶ | US National | 37.2 (35.1-39.3) | 35.0 (32.9-37.2) | 35.7 (29.6-42.4) | 44.4 (38.0-50.9) | 52.8 (35.4-69.6) | 40.6 (27.6-55.2) |
| At or Above Poverty | 35.8 (33.7-37.9) | 35.7 (33.5-38.0) | 31.2 (25.3-37.8) | 39.3 (31.7-47.4) | 51.3 (30.8-71.3) | 41.6 (26.5-58.6) | |
| Below Poverty | 46.4 (39.8-53.1) | 33.6 (27.0-40.8) | 45.9 (32.0-60.4) | 53.0 (41.9-63.9) | 54.5 (24.8-81.3) | NA | |
| Unknown Poverty | 31.1 (23.5-39.9) | 25.2 (17.3-35.1) | NA | NA | NA | NA |
| * Estimate presented as point estimate (%) ± 95% confidence interval (CI). Estimate=NA (Not Available) if the unweighted sample size for the denominator was <30 or (CI half width)/Estimate > 0.6. | ||||||||||||
| † Estimate may be unreliable; (CI width)>20. | ||||||||||||
| § Adolescents in the 2008 NIS-Teen were born during January 1990 - February 1996. Vaccination coverage estimates include only adolescents who had adequately complete provider-reported immunization records. | ||||||||||||
| ¶ Based on family income and household size using US Bureau of Census poverty thresholds for 2007. | ||||||||||||
| ** Reported by respondent. Adolescents identified as White, Black, American Indian/Alaska Native, Asian, or Native Hawaiian/Pacific Islander are all non-Hispanic. Adolescents of Hispanic ethnicity may be of any race. Reported by respondent. | ||||||||||||
| †† Includes > 2 doses of measles-mumps-rubella vaccine | ||||||||||||
| §§ Includes > 3 doses of hepatitis B vaccine. | ||||||||||||
| ¶¶ Includes > 1 dose of varicella vaccine among adolescents without a history of varicella disease. | ||||||||||||
| *** Includes > 1 dose of tetanus toxoid-diphtheria vaccine (Td) or tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since the age of ten years. | ||||||||||||
| ††† Includes > 1 dose tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since the age of ten years. | ||||||||||||
| §§§ Includes percentages receiving meningococcal conjugate vaccine (MCV4) and meningococcal -unknown type vaccine. | ||||||||||||
| ¶¶¶ Quadrivalent human papillomavirus vaccine. Percentages reported among females only since HPV4 vaccine is only recommended for females. | ||||||||||||
| tab16_race_pov2 | ||||||||||